Transfusion in trauma: why and how should we change our current practice?

Area of Science:

• Trauma Care
• Hemorrhage Management
• Coagulation Disorders

Background:

• Major trauma frequently leads to hemorrhage and blood product transfusion, both linked to adverse clinical outcomes.
• Hemorrhage is a primary cause of early mortality in trauma patients, exacerbated by coagulopathy.
• Transfusion of blood components, while critical, carries inherent risks and requires careful benefit-harm assessment.

Purpose of the Study:

• To underscore the importance of vigilant bleeding and coagulation monitoring in trauma patients.
• To explore the rationale for current and future transfusion strategies in trauma care.

Main Methods:

• Review of current literature on trauma-associated hemorrhage and coagulopathy.
• Analysis of diagnostic tools, including routine and bedside coagulation tests and blood gas analysis.
• Discussion of evidence-based transfusion strategies in civilian and non-civilian settings.

Main Results:

• Early identification of hemorrhage causes via coagulation testing enables goal-directed treatment.
• Effective management of coagulopathy and anemia can halt bleeding and decrease transfusion requirements.
• Adverse outcomes associated with blood product transfusion necessitate a balanced approach to treatment decisions.

Conclusions:

• Future transfusion strategies will rely on continuous assessment of bleeding and coagulation status.
• Specific, goal-directed treatments optimize coagulation, minimize blood product exposure, reduce costs, and improve patient outcomes.